US Stock MarketDetailed Quotes

CAMP Camp4 Therapeutics

Watchlist
  • 5.200
  • -0.140-2.62%
Close Dec 20 16:00 ET
  • 5.200
  • 0.0000.00%
Post 16:20 ET
104.84MMarket Cap-1.97P/E (TTM)

Camp4 Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Sep 30, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(FY)Dec 31, 2022
Total revenue
0
350K
0
350K
0
Operating revenue
--0
--350K
--0
--350K
--0
Cost of revenue
Gross profit
Operating expense
6.53%13.52M
16.06%52.23M
13.48M
12.69M
45M
Selling and administrative expenses
32.94%3.81M
13.52%11.61M
--2.82M
--2.87M
--10.23M
-General and administrative expense
32.94%3.81M
13.52%11.61M
--2.82M
--2.87M
--10.23M
Research and development costs
-1.19%9.7M
16.81%40.62M
--10.66M
--9.82M
--34.77M
Operating profit
-9.55%-13.52M
-15.28%-51.88M
-13.48M
-12.34M
-45M
Net non-operating interest income expense
-86.36%94K
210.62%2.81M
569K
689K
904K
Non-operating interest income
-86.36%94K
210.62%2.81M
--569K
--689K
--904K
Other net income (expense)
-31.91%-62K
-131.58%-220K
-83K
-47K
-95K
Other non- operating income (expenses)
-31.91%-62K
-131.58%-220K
---83K
---47K
---95K
Income before tax
-15.29%-13.48M
-11.54%-49.29M
-12.99M
-11.7M
-44.19M
Income tax
Net income
-15.29%-13.48M
-11.54%-49.29M
-12.99M
-11.7M
-44.19M
Net income continuous Operations
-15.29%-13.48M
-11.54%-49.29M
---12.99M
---11.7M
---44.19M
Minority interest income
Net income attributable to the parent company
-15.29%-13.48M
-11.54%-49.29M
-12.99M
-11.7M
-44.19M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
-15.29%-13.48M
-11.54%-49.29M
-12.99M
-11.7M
-44.19M
Basic earnings per share
28.34%-0.6913
-12.22%-4.09
-1.0714
-0.9646
-3.6448
Diluted earnings per share
28.34%-0.6913
-12.22%-4.09
-1.0714
-0.9646
-3.6448
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
(Q3)Sep 30, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(FY)Dec 31, 2022
Total revenue 0350K0350K0
Operating revenue --0--350K--0--350K--0
Cost of revenue
Gross profit
Operating expense 6.53%13.52M16.06%52.23M13.48M12.69M45M
Selling and administrative expenses 32.94%3.81M13.52%11.61M--2.82M--2.87M--10.23M
-General and administrative expense 32.94%3.81M13.52%11.61M--2.82M--2.87M--10.23M
Research and development costs -1.19%9.7M16.81%40.62M--10.66M--9.82M--34.77M
Operating profit -9.55%-13.52M-15.28%-51.88M-13.48M-12.34M-45M
Net non-operating interest income expense -86.36%94K210.62%2.81M569K689K904K
Non-operating interest income -86.36%94K210.62%2.81M--569K--689K--904K
Other net income (expense) -31.91%-62K-131.58%-220K-83K-47K-95K
Other non- operating income (expenses) -31.91%-62K-131.58%-220K---83K---47K---95K
Income before tax -15.29%-13.48M-11.54%-49.29M-12.99M-11.7M-44.19M
Income tax
Net income -15.29%-13.48M-11.54%-49.29M-12.99M-11.7M-44.19M
Net income continuous Operations -15.29%-13.48M-11.54%-49.29M---12.99M---11.7M---44.19M
Minority interest income
Net income attributable to the parent company -15.29%-13.48M-11.54%-49.29M-12.99M-11.7M-44.19M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders -15.29%-13.48M-11.54%-49.29M-12.99M-11.7M-44.19M
Basic earnings per share 28.34%-0.6913-12.22%-4.09-1.0714-0.9646-3.6448
Diluted earnings per share 28.34%-0.6913-12.22%-4.09-1.0714-0.9646-3.6448
Dividend per share
Currency Unit USDUSDUSDUSDUSD
Heat List
US
Overall
Symbol
Price
% Chg

No Data

Investment Theme Recent IPOs
Recent IPOs
Intraday+0.71%